Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisugabalin besylate real-world cohort study for migraine prophylaxis
ChiCTR2600133996Phase 4Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of crisugabalin besilate in migraine, sponsored by Beijing Tiantan Hospital. Primary endpoint: Migraine days. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
crisugabalin besilate
03
Conditions
migraine
Beyond the preview
Go deeper on ChiCTR2600133996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133996.